New candidate to treat progressive supranuclear palsy (PSP) reports positive phase2a results and warrants future clinical trials
Read Full Article
#PSP #NeurodegenerativeDisease #ClinicalTrials
Read Full Article
#PSP #NeurodegenerativeDisease #ClinicalTrials
International Parkinson and Movement Disorder Society
Phase 2a Randomized Controlled Trial of <fc>TPN</fc>‐101, A Nucleoside Reverse Transcriptase Inhibitor, in Progressive Supranuclear…
Background
Preclinical and human brain postmortem studies indicate that progressive supranuclear palsy (PSP) is associated with increased expression of the retrotransposon Long Interspersed Nuclear ...
Preclinical and human brain postmortem studies indicate that progressive supranuclear palsy (PSP) is associated with increased expression of the retrotransposon Long Interspersed Nuclear ...